The acquisition of invasiveness in ovarian cancer (OC) is accompanied by the process of epithelial-to-mesenchymal transition (EMT). The MUC4 mucin is overexpressed in ovarian tumors and has a role in the invasiveness of OC cells. The present study was aimed at evaluating the potential involvement of MUC4 in the metastasis of OC cells by inducing EMT. Ectopic overexpression of MUC4 in OC cells (SKOV3-MUC4) resulted in morphological alterations along with a decreased expression of epithelial markers (E-cadherin and cytokeratin (CK)-18) and an increased expression of mesenchymal markers (N-cadherin and vimentin) compared with the control cells (SKOV3-vector). Also, pro-EMT transcription factors TWIST1, TWIST2 and SNAIL showed an upregulation in SKOV3-MUC4 cells. We further investigated the pathways upstream of N-cadherin, such as focal adhesion kinase (FAK), MKK7, JNK1/2 and c-Jun, which were also activated in the SKOV3-MUC4 cells compared with SKOV3-vector cells. Inhibition of phospho-FAK (pFAK) and pJNK1/2 decreased N-cadherin expression in the MUC4-overexpressing cells, which further led to a significant decrease in cellular motility. Knockdown of N-cadherin decreased the activation of extracellular signal-regulated kinase-1/2 (ERK1/2), AKT and matrix metalloproteinase 9 (MMP9), and inhibited the motility in the SKOV3-MUC4 cells. Upon in vivo tumorigenesis and metastasis analysis, the SKOV3-MUC4 cells produced significantly larger tumors and demonstrated a higher incidence of metastasis to distance organs (peritoneal wall, colon, intestine, stomach, lymph nodes, liver and diaphragm). Taken together, our study reveals a novel role for MUC4 in inducing EMT through the upregulation of N-cadherin and promoting metastasis of OC cells.
Introduction
Epithelial-to-mesenchymal transition (EMT) is a transdifferentiation process characterized by coordinated molecular and cellular changes defined by a reduction in cell-cell adhesion and loss of apical-basolateral polarity (Thiery, 2002) . The gain of mesenchymal markers and the loss of epithelial markers, the hallmarks of EMT, as well as altered morphological features associated with this process inducing increased motility and invasion of cancer cells (Thiery, 2002; Ahmed et al., 2007) . EMT is also involved in cancer progression and metastasis and it is probable that a common molecular mechanism is shared by these processes (Thiery, 2002; Ahmed et al., 2007) . EMT occurs during ovarian cancer (OC) progression in response to various stimuli. However, the underlying mechanisms are not well established in OC.
The MUC4 mucin is a large glycoprotein that frequently displays an altered expression in several cancers (Andrianifahanana et al., 2001; Carraway et al., 2001; Hollingsworth and Swanson, 2004; Chaturvedi et al., 2007; Ponnusamy et al., 2008 ). An overexpression of MUC4 mRNA has been reported in OC (Giuntoli et al., 1998; Lopez-Ferrer et al., 2001) and in an earlier study, we have shown that MUC4 is aberrantly expressed in >90% of malignant ovarian tumors with very low to an undetectable expression in the normal ovary (Chauhan et al., 2006) . These observations suggest that MUC4 may have a major role in the pathogenesis of OC. The domain organization of MUC4 suggests that it is a membrane-anchored protein containing two subunits, MUC4a (an extracellular mucin-type glycoprotein subunit) and a MUC4b transmembrane subunit with a short cytoplasmic tail (Nollet et al., 1998; Moniaux et al., 1999) . The juxtamembrane domain of the MUC4 has also been suggested to induce the metastatic cellular characteristics and signaling by interacting with epidermal growth factor receptors (that is, HER2 via any of its three epidermal growth factor domains; Chaturvedi et al., 2007; Ponnusamy et al., 2008) . Further, we have reported that MUC4 activates the focal adhesion kinase (FAK) in pancreatic and OC cells Ponnusamy et al., 2008) . In our previous studies, we have observed MUC4-induced phenotypic variation and signaling alteration in pancreatic cancer and OC cells Ponnusamy et al., 2008) , which encourages us to further look into its role in EMT and cadherin alterations. Cadherins are transmembrane glycoproteins belonging to a large family of calciumdependent cell-cell adhesion molecules that have important roles in maintaining normal histoarchitechture, cell polarity, embryonic development and signal transduction (Behrens, 1994; Chen et al., 1997; Hazan et al., 2004) . The altered expression of E-cadherin and N-cadherin has been shown to strongly affect motility, aggregation, invasive and adhesive properties of a large variety of cells (Kondo et al., 1998; Auersperg et al., 1999; Hazan et al., 2000) . The upregulation of N-cadherin has also been shown to promote tumor growth, invasion and metastasis, and knockdown of cJun prevents N-cadherin upregulation and limited tumor growth and invasion in a mouse model for pancreatic cancer (Shintani et al., 2008) .
The current study was designed to test the hypothesis that MUC4 signaling promotes EMT, thereby increasing the metastatic nature of human OC cells. Our results suggest that MUC4 could be a potential candidate for inducing EMT by altering the expression/activation of metastasis promoting signaling molecules.
Results

Overexpression of the MUC4 mucin in human OC cells
We have generated a MUC4 gene construct (B9 kb) to overcome the transfection-associated problems owing to the large size (27 kb) of MUC4 mRNA, and investigated the biological function and effect of MUC4 expression Ponnusamy et al., 2008) . MUC4-negative OC cell lines, SKOV3 and OVCAR3, were selected for analyzing the role of MUC4 in OC. The MUC4 construct is similar to the wild-type MUC4 except for the tandem repeat region, which is 10% the size of the wild-type allele Ponnusamy et al., 2008) . The expression of MUC4 in stable cell transfectants was evaluated by immunoblotting and confocal analysis using a MUC4 antibody (8G7) that recognizes an epitope in the tandem repeat domain of MUC4. This antibody recognizes a MUC4 protein band of B322 kDa, specifically in MUC4-transfected cells (SKOV3-MUC4 and OVCAR3-MUC4) and not in the vector-transfected cells (SKOV3-vector and OVCAR3-vector; Figure 1a and Supplementary Figure 1) . The expression and subcellular localization of MUC4 was further confirmed by immunofluorescence and confocal microscopy. A total of 90% of the SKOV3-MUC4-transfected cells showed localization of MUC4 in both the plasma membrane and cytoplasm (Figure 1a ) MUC4 is undetectable in the vector-transfected SKOV3 cells (Figure 1a ).
MUC4 overexpression induces a mesenchymal phenotype in OC cells
We further analyzed the morphology and changes in the actin-cytoskeleton of MUC4-expressing SKOV3 cells. Phase contrast microscopy image revealed that the cells underwent a morphological change, from cobblestonelike cell morphology to an elongated and spindle-like morphology (mesenchymal phenotype), with reduced cell-cell contact ( Figure 1a ) compared with vectortransfected cells. Polymerization of globular actin leads to the formation of long fibrous molecules called filamentous actin (Cunningham et al., 1992) . The localization and distribution of filamentous actin were analyzed by phalloidin staining in both MUC4-overexpressing and vector-transfected SKOV3 cells. Confocal microscopy of the phalloidin-stained cells also confirmed the presence of filopodia, lammelopodia and microspikes in the MUC4-transfected cells (Figure 1a) . The vector-transfected SKOV3 cells showed less staining and did not show any cellular outgrowth (Figure 1a ).
MUC4 expression alters the expression of EMT markers in OC cells
To investigate the mechanism underlying the morphological changes, we examined the expression of well-known epithelial markers (E-cadherin (CDH1), cytokeratin (CK)-18) and mesenchymal markers (N-cadherin (CDH2), and vimentin (VIM)) in the MUC4-and the MUC4-transfected SKOV3 cells (Figure 1b) . CK-18 expression in the SKOV3-vector cells was strong and exhibited a filamentous pattern, whereas it was significantly less in SKOV3-MUC4 cells (Figure 1c ). In contrast, N-cadherin ( Figure 1d ) and vimentin ( Figure 1e ) showed increased staining in the MUC4-transfected SKOV3 cells as compared with control cells. The decreased expression of E-cadherin and increased expression of N-cadherin were also seen in OVCAR3 cells transiently transfected with MUC4, suggesting that the observed effects are not limited to a single OC cell line (Supplementary Figure 1) . These results demonstrate that the expression of EMT-associated markers is increased in a coordinated manner in MUC4-overexpressing OC cells. Further, the mRNA expression of TWIST1, TWIST2 and SNAIL, key transcription factors that promote EMT, was significantly increased in the SKOV3-MUC4 cells compared with vector-transfected cells (Figure 1f ), suggesting that MUC4 expression induces EMT in OC cells. Inhibition of phospho-FAK (pFAK) and pJNK1/2 decreases the level of N-cadherin and its downstream signaling FAK was inhibited with a small molecule inhibitor-14 (1,2,4,5-benzenetetraamine tetrahydrochloride), which targets the Tyr397 phosphorylation site on FAK (Golubovskaya et al., 2008) . By using different doses (10 and 50 mM) of FAK inhibitor-14 for 12 h, we observed a concentration-dependent decrease in the activation of FAK in MUC4-transfected SKOV3 cells ( Figure 2b ). All other FAK downstream signaling molecules (MKK7, JNK1/2 and c-Jun) were also analyzed under similar conditions. MKK7, JNK1/2 and c-Jun molecules showed decreased activation in the FAK inhibitor-treated SKOV3-MUC4 cells compared with untreated cells (Figure 2c ). The total form of MKK7, JNK1/2 and c-Jun, however, remained unchanged ( Figure 2c ). Interestingly, N-cadherin expression was also significantly decreased in the 
MUC4 decreases aggregation and increases clonogenicity of SKOV3 cells
To analyze the functional activity of MUC4 in OC cells, we primarily performed in vitro hanging drop cell aggregation and colony forming assays. The MUC4-expressing cells showed less aggregation whereas the vector-transfected SKOV3 cells exhibited large and tightly attached cell aggregates after 12 h incubation in hanging drop analysis ( Figure 3a ). It is a well-known factor that cancer cells possess an increased efficiency of colonization than the normal cells. The colony-forming efficiency of SKOV3-MUC4 and vector-transfected cells was investigated by seeding 500 cells in a 10 mm culture dish and counting visible colonies after 3 weeks. MUC4-overexpressing cells showed a significantly higher number of colonies (*P ¼ 0.029) than the vectortransfected cells (Figure 3b ).
MUC4 induces motility and the invasive property of SKOV3 cells
We further performed a wound healing assay to qualitatively observe the effect of MUC4-induced motility in SKOV3 cells. The scratch was made in 90% confluence of MUC4-and vector-transfected SKOV3 cells. After allowing the cells to move into the scratch wound for 12 h, we observed an increase in the number of cells that moved into the scratch wound in the MUC4-transfected cells compared with vectortransfected cells (Figure 3c ). The quantitative cellular motility was also analyzed in both cells using Boyden's chamber assay. MUC4-transfected cells showed a significant (*P ¼ 0.0001) increase in motility when compared with the vector-transfected SKOV3 cells (Figure 3d ). The morphological variation and decreased aggregation in MUC4-overexpressed cells may induce significant cell motility. The presence of structures like lammelopodia, filopodia and microspikes may be a cause of increased motility in the MUC4-transfected cells. To investigate the invasion capacity of MUC4-transfected SKOV3 cells, an in vitro invasion assay was performed. The MUC4-transfected SKOV3 cells showed a highly significant (*P ¼ 0.000055) increase in the number of invading cells compared with vectortransfected cells (Figure 3e ).
Effect of MUC4 on Akt, extracellular signal-regulated kinase-1/2 (ERK1/2) signaling and matrix metalloproteinase 9 (MMP9) expression in OC cells The effect of MUC4 on Akt, ERK1/2 signaling and also on MMP9 was analyzed by immunoblotting. The MUC4-overexpressing SKOV3 and OVCAR3 cells showed a significant increase in the activated Akt (Ser473), ERK1/2, although the total levels of these proteins remained unchanged (Figure 4a; Supplementary Figure 1) . The threonine (308) phosphorylation of Akt did not show any activation in both MUC4-and vector-transfected SKOV3 cells (Figure 4a ). We also observed an increased level of MMP9 expression in MUC4-transfected but not in vector-transfected OC cells (Figure 4a) .
The aforementioned results suggest that MUC4 upregulates N-cadherin through FAK and its downstream signaling molecules MKK7, JNK1/2 and c-Jun (Figures 2b and c) . We further analyzed Akt, ERK1/2 Inhibition of pFAK and pJNK1/2 decreases the motility Scratch assays were performed in both FAK inhibitor-and JNK1/2 inhibitor-treated MUC4-overexpressing SKOV3 cells. Significant inhibition of motility was observed in the FAK inhibitor-and JNK1/2 inhibitor-treated cells compared with the untreated cells (Figures 4c and d) . These results suggest that MUC4-induced activation of FAK and JNK1/2 leads to the increased motility of OC cells.
Knockdown of N-cadherin reduces the motility in SKOV3-MUC4 cells
To further establish the importance of N-cadherin in MUC4-induced motility, we silenced the expression of N-cadherin in SKOV3-MUC4 cells using N-cadherinspecific small interfering RNA (siRNA) oligos. Ncadherin was 50% downregulated in siRNA-treated cells compared with scramble RNA interference-treated cells (Figure 5a ). The downregulation of N-cadherin was associated with a decreased activation of Akt (Ser473), ERK1/2 and decreased expression of MMP9 when compared with the scramble RNA interference-treated cells (Figure 5a ). The total form of Akt, ERK1/2 remained unchanged in both the cells. Additionally, we also performed a motility assay in the N-cadherin siRNA-and scramble siRNA-treated SKOV3-MUC4 cells. A significant (*P ¼ 0.004) reduction in motility was observed in the N-cadherin siRNA-treated SKOV3-MUC4 cells compared with those treated with scrambled RNA interference. These results confirmed that MUC4 induces the motility and invasion through Akt, ERK1/2 and MMP9 pathways in OC cells.
Overexpression of MUC4 induces tumorogenecity and metastasis of SKOV3 cells
To test the hypothesis that MUC4 has a role in tumor development and metastasis, we compared the tumorigenicity and metastatic potential of MUC4-transfected SKOV3 cells with vector-transfected cells by in vivo analysis. SKOV3-MUC4 and SKOV3-vector cells were injected subcutaneously (s.c.) into athymic nude mice (six animals per group). All mice were killed and tumors were dissected at the end of the experiment. Tumor size was measured every alternate day up to 34 days. The mean tumor volumes produced by the vector-and MUC4-transfected SKOV3 cells are represented graphically (Figure 6a) . A comparison of the tumor weight and volume between the vector-and MUC4-transfected SKOV3 cells showed a significantly higher tumor volume and weight (P ¼ 0.00001) in the mice injected with the MUC4-transfected SKOV3 cells compared with those injected with control cells (Figure 6b) .
To examine the effect of MUC4 on metastasis, a total of eight immunodeficient mice were intraperitoneally (i.p.) injected with SKOV3-vector and SKOV3-MUC4 cells in two different sets of experiments and killed after thirty-second day of the experiment. Tumors were observed in the ovaries of both SKOV3-vector-and SKOV3-MUC4-injected mice. Mice injected with the MUC4-overexpressing cells showed greater ascitic fluid accumulation in the peritoneal cavity than in control mice (Figure 6c ). The incidence of metastases present in 
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the distant organs, including the liver, pelvic peritoneal wall, diaphragm, lymph nodes, stomach, colon and intestine, were documented ( Figure 6c and Table 1 ).
Most of the mice injected with MUC4-expressing SKOV3 cells (n ¼ 8) developed metastases (large metastatic nodules) at multiple sites, whereas the mice injected with the control cells (n ¼ 8) exhibited metastatic (fewer and smaller metastatic lesions) deposits only at a few sites ( Table 1 ). The incidence of liver (P ¼ 0.022), diaphragm (P ¼ 0.05), lymph node (P ¼ 0.05), stomach (P ¼ 0.02) and pelvic peritoneal wall (P ¼ 0.082) metastasis was significantly higher in the SKOV3-MUC4 cells injected mice compared with the SKOV3-vector-injected mice. The incidence of colon (P ¼ 0.22) and intestinal (P ¼ 0.42) metastasis was not significantly different between the two groups of mice (Table 1 ). The tumor was dissected from the peritoneum and stained with hematoxylin and eosin for both MUC4-transfected and control SKOV3 cells injected mice (Figure 6d ). It was also stained for MUC4 and Ncadherin antibodies. The immunoreactivity of MUC4 and N-cadherin was higher in SKOV3-MUC4-injected tumors as compared with SKOV3-vector-injected mice tumors (Figure 6d ).
Discussion
This study has three salient findings. First, MUC4 overexpression induces an elongated and spindle-like morphology (mesenchymal phenotype) and significant alteration of EMT markers in OC cells. Second, MUC4 activates the FAK pathway and upregulates the expression of N-cadherin in OC cells. Third, MUC4-induced N-cadherin is involved in the metastasis of OC cells. To the best of our knowledge, this is the first report suggesting the novel role of MUC4 in the induction of EMT and metastasis in OC cells.
EMT is associated with a loss of epithelial and gain of mesenchymal characteristics, resulting in increased invasive potential in epithelial cancer (Thiery, 2002; Ahmed et al., 2007) . Previous studies have shown that MUC4 is overexpressed in many carcinomas, including ovarian carcinoma (Boman et al., 2001; Chauhan et al., 2006) . A recent study by our group suggested that MUC4 has a major role in pancreatic and OC cell motility, in part, by altering downstream signaling Ponnusamy et al., 2008) . The current study addresses the importance of MUC4 in induction of mesenchymal phenotype and investigated the underlying molecular mechanism. Our result indicates that MUC4-transfected SKOV3 cells showed mesenchymal phenotype with phalloidin staining. Similarly, a previous report had shown that the phalloidin staining helps to clearly visualize the alterations of actin-cytoskeleton rearrangement and morphological variation (Theriault et al., 2007) . Further, the loss of epithelial markers E-cadherin and CK-18, (Ahmed et al., 2007; Gravdal et al., 2007; Kolosionek et al., 2009 ) and gain of mesenchymal markers N-cadherin and vimentin (Thiery, 2002; Ahmed et al., 2007; Gravdal et al., 2007; Kolosionek et al., 2009) are the hallmarks of EMT. In addition to the morphological changes, overexpression of MUC4 resulted in a similar loss of epithelial markers and a gain of mesenchymal markers, suggesting that MUC4 is actively involved in the EMT process in OC cells (Figure 1) . A recent study revealed that another mucin, MUC1, is involved in inducing the EMT process by engaging it with various signaling modules (Horn et al., 2009) and also supports our finding of mucin-mediated EMT. Furthermore, the EMT associated key transcription factors TWIST1, TWIST2 and SNAIL (Kang and Massague, 2004; Kudo-Saito et al., 2009 ) also showed an increased expression in the MUC4-transfected cells (Figure 1) . These results also suggest that MUC4 induces EMT in OC cells.
Based on a recent finding of FAK-mediated upregulation of N-cadherin in the pancreatic cancer cell line (Shintani et al., 2008) , we further elucidated the mechanism underlying MUC4-induced upregulation of N-cadherin through the activation of the FAK signaling pathway in human OC cells (Figure 2 ). This finding provides mechanistic support to our previous study (Chauhan et al., 2006; Ponnusamy et al., 2008) , which indicated that MUC4 overexpression is associated with increased metastatic potential and a poor prognosis in OC. Our results in the present study clearly demonstrated that the overexpression of MUC4 induces activation of FAK and its downstream molecules, such as MKK7, JNK1/2 and c-Jun, and hence upregulates N-cadherin in OC cells. These results confirmed, for the first time, that MUC4 induces the upregulation of N-cadherin expression through FAK and the JNK1/2 pathway in OC cells. In addition, recent reports have clearly established a switch between E-cadherin to N-cadherin expression during the EMT process in various epithelial cancers (Maeda et al., 2005; Gravdal et al., 2007) .
EMT is thought to be a key step in tumor metastasis via the induction of a highly invasive phenotype, and its molecular mechanisms have been extensively studied (Thiery, 2002) . MUC4 overexpression induces dramatic variation in OC cell morphology and decreases aggregation, and increases colony formation, motility and invasion, suggesting that MUC4 may promote the metastatic property in OC cells. In one of our earlier studies, we showed that MUC4 caused an alteration in The incidence of metastasis was compared between the SKOV3-vector and SKOV3-MUC4 cells injected mice by the w 2 -test. A *P-value of 00.05 was considered statistically significant. * indicates the significance of metastatic incidences between two groups. motility and aggregation of pancreatic and OC cells (Singh et al., 2004; Ponnusamy et al., 2008) . The aberrant overexpression of MUC4 on the entire cell surface in cancer cells may constantly engage itself in stimulating the downstream molecules and upregulates N-cadherin expression, and thereby induce the EMT and promote the metastatic behavior of the OC cells.
Furthermore, we observed an increase in the activation of Akt (Ser473), ERK1/2 and an increased expression of MMP9 in MUC4-transfected SKOV3 cells, which is decreased when N-cadherin is silenced in the same cells, leading to decreased motility ( Figure 5) . A previous report lends support to our finding that in the presence of N-cadherin, FGF2 causes sustained activation of the MAPK-ERK pathway, leading to MMP9 transcriptional upregulation and enhanced cellular invasion (Suyama et al., 2002) . In our study, the increased phosphorylation of ERK1/2 may lead to an upregulation of MMP9 and induce the invasion of OC cells. In addition, the activation of Akt (Ser473) could also be involved in the survival and migration of OC cells (Ponnusamy et al., 2008) . Interestingly, the inhibition of pFAK and pJNK1/2 in MUC4-overexpressed OC cells resulted in a significant decrease in cell migration, suggesting that MUC4-induced activation of FAK and the subsequent increase in N-cadherin expression may be the cause of increased motility in OC cells. A study by Hazan et al. (1997) reported that N-cadherin expression is significantly higher in more invasive, less differentiated cancer cell lines that lacked E-cadherin expression (Hazan et al. 1997) .
The induction of N-cadherin with MUC4 expression also correlated with an increased incidence of tumor metastasis in vivo, suggesting a role of MUC4 in the potentiation of tumor metastasis. In vivo metastasis of tumor cells is an extremely complicated process that involves several consecutive events (that is, EMT, detachment of tumor cells from primary site, intravasation into blood stream, evasion of immune surveillance, adherence to vascular endothelial cells of distant organs and finally extravasation into tissues followed by MET) (Fidler, 1990; Folkman, 1990) . Membrane-bound mucins are considered to be the important determinants of the cell's adhesive properties and therefore its metastatic potential, even in cases where the level of known adhesion molecules remain unchanged (Sommers, 1996; Truant et al., 2003) . Our in vivo tumorigenesis and metastasis analysis showed that there is a significant increase in tumor formation and incidence of metastasis in the liver, peritoneal wall, diaphragm, lymph nodes, stomach and also more ascitic fluid accumulation in MUC4-overexpressing OC cells. Further the tumors from MUC4-expressing cells showed increased immunoreactivity for MUC4 and N-cadherin compared with control tumors. These in vivo results confirmed that MUC4 induces N-cadherin expression in vivo and this may be involved in the metastasis of OC.
In conclusion, we provide the first evidence that MUC4 induces EMT by altering the levels of epithelial and mesenchymal markers in OC cells. The underlying mechanism involves disruption of E-cadherin expression, increased activation of FAK, MKK7, JNK1/2 and c-Jun that further leads to an upregulation of N-cadherin. N-cadherin further may activate downstream effectors like ERK1/2, Akt leading to the increased expression of MMP9, which may be the primary cause of decreased aggregation, increased motility and invasiveness of OC cells (Figure 7) . The in vivo results also confirmed that MUC4 increases the tumorigenicity and metastatic nature of OC cells through the induction of N-cadherin. Overall, our results strongly suggest for the first time that MUC4 induces EMT and has a determinative role in regulating the growth, motility, invasiveness and metastatic potential of OC cells by upregulating the expression of N-cadherin via the FAK signaling pathway.
Materials and methods
Generation of MUC4 construct
We generated a MUC4 gene construct to overcome the transfection-associated problems owing to its large size and to investigate the biological function and effect of MUC4 expression in OC cells. Ponnusamy et al., 2008) . The resultant MUC4 complementary DNA was sub-cloned into the pSecTag-C vector for further transfection studies.
Cell culture and transfection procedure SKOV3 and OVCAR3 cells were procured from American Type Culture Collection (Manassas, VA, USA) and cultured in Dulbecco 0 s modied Eagle 0 s medium and RPMI medium, respectively, supplemented with 10% fetal calf serum and antibiotics. The MUC4 gene construct, along with the empty vector control pSecTag-C, were transfected in SKOV3 OC cells by Fugene (Invitrogen, Carlsbad, CA, USA), following the manufacturer's protocol. Transfected cells were selected in the medium containing 200 mg/ml zeocin (30 days) and the drug resistance (zeo þ ) clones (three from the empty vector, five from the MUC4 gene construct transfected) were selected from different plates and studied after expansion. OVCAR3 cells were used for the transient transfection of MUC4 and vector control plasmids for 72 h. The transient knockdown (48 h) of N-cadherin was carried out in SKOV3-MUC4 cells using a pool of three siRNA oligos specific for N-cadherin and with control oligos (Santa Cruz Biotechnologies, Santa Cruz, CA, USA).
Immunoblot assay SKOV3-derived cell lines were processed for protein extraction and western blotting using standard procedures. SDS-agarose (2%) gel electrophoresis was performed for MUC4 using 20 mg protein samples under reducing conditions. For E-cadherin, N-cadherin, CK-18, vimentin, FAK, MKK7, JNK1/2, c-Jun, ERK, Akt, MMP9 and b-actin expression, SDS-polyacrylamide gel electrophoresis (10%) was performed under similar conditions. Resolved proteins were transferred on to the polyvinylidene fluoride membrane and immunoblot assay was performed for the above mentioned proteins (for details see Supplementary Information).
Confocal immunofluorescence microscopy MUC4-and vector-transfected SKOV3 cells were grown on sterilized cover slips for 20 h and MUC4, E-, N-cadherin, CK-18 and vimentin antibodies were used for immunofluorescence analysis (detailed procedure there in Supplementary Information).
Inhibition of pFAK and pJNK1/2 in SKOV3-MUC4 cells SKOV3-MUC4 cells (3 Â 10 6 ) were seeded and, after 12 h, cells were treated with small molecule inhibitor-14 (1,2,4,5-benzenetetraamine tetrahydrochloride) for 12 h (Golubovskaya et al., 2008) in different doses (10 and 50 mM). The inhibition of pJNK1/2 was also carried out in MUC4-overexpressed SKOV3 cells. The pJNK1/2 inhibitor SP600125 (20, 40 and 80 nM) was used to treat SKOV3-MUC4 cells for 12 h. After the inhibition of pFAK and pJNK1/2, cells were used to extract the protein for further western blot analysis.
Aggregation assay
Aggregation assay was carried out with SKOV3-vector and SKOV3-MUC4 cells (detailed procedure there in Supplementary Information).
Wound healing assay
The scratch was made across the cell monolayer in OC cells. The cells were allowed to incubate for 12 h and images taken in six different fields. After 12 h, the migration of cells was measured (mm 2 ) by using DatInf Measure setup Wizard software (http://tucows.texasonline.net). The significant migration of cells was analyzed using two-tailed Student's t-test. A P-value of o0.05 was considered statistically significant.
Cell motility and invasion assay
We have performed motility and invasion assays using chamber with monolayer-coated polyethylene teraphthalate membranes (six-well insert, pore size of 8 mm; Becton Dickinson, Franklin Lakes, NJ, USA) and Matrigel-coated membrane inserts (BD Biosciences, Bedford, MA, USA) for both SKOV3-vector and SKOV-MUC4 cells respectively (detailed procedure given in Supplementary Information).
Colony forming assay Cells were seeded in triplicate at 500 cells/10-cm dishes in complete medium. After 2 weeks of growth, the cells were fixed and stained with crystal violet stain (0.1%, w/v in 20 nM 4-morpholinepropanesulfonic acid; Sigma Chemicals, St Louis, MO, USA), and the grossly visible colonies were counted. All experiments were repeated at least three times. Plating efficiency was determined as the number of colonies formed divided by the total number of cells plated.
In vivo tumor growth and metastasis To test the tumorigenicity, the MUC4-transfected SKOV3 cells, along with the control cells were subcutaneously injected into immunodeficient female mice (n ¼ 6 for each group) and tumor growth was followed for 34 days. To analyze the effect of the overexpression of MUC4 on the metastatic property of SKOV3 cells, we have performed intraperitoneal injection (i.p.) in immunodeficient female mice (n ¼ 8 for each group). We have observed distant organ metastasis on thirty-second day after the implantation of the tumor cells (detailed procedure in Supplementary Information).
Histological and immunohistochemical analysis
The tumors were dissected from i.p. injected animals (in both SKOV3-vector and SKOV3-MUC4 cells) and fixed in 4% paraformaldehyde in phosphate-buffered saline overnight and subsequently embedded in paraffin wax. Sections were cut at a thickness of 4 mm and stained with hematoxylin and eosin for histological analysis. Immunohistochemical analysis was also performed for MUC4 and N-cadherin in tumors developed from both type of cells (SKOV3-vector and SKOV3-MUC4 cells) as described previously Singh et al., 2004 ; detailed procedure in Supplementary Information).
Statistical analysis
Different statistical analysis (two-tailed Student's t-test and two-tail Fisher's exact test) was performed for these studies and details are given in Supplementary Information.
